Increased levels of clusters of differentiation contributing to macrophage survival in tumor metastasis and their differentiation into pro-inflammatory F4/80+ macrophages in the liver (i.e., CX3CR1+CD74+) associated with a better survival rate allow for the results to be interpreted as supporting myeloid-derived antitumoral responses. The gene discussed is CD74; the disease is neoplasm.